PROMETHAZINE W Drug Patent Profile
✉ Email this page to a colleague
When do Promethazine W patents expire, and when can generic versions of Promethazine W launch?
Promethazine W is a drug marketed by Cenci, Wockhardt Bio Ag, and Pharm Assoc. and is included in three NDAs.
The generic ingredient in PROMETHAZINE W is dextromethorphan hydrobromide; promethazine hydrochloride. There are twenty-three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; promethazine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROMETHAZINE W?
- What are the global sales for PROMETHAZINE W?
- What is Average Wholesale Price for PROMETHAZINE W?
Summary for PROMETHAZINE W
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| DailyMed Link: | PROMETHAZINE W at DailyMed |
US Patents and Regulatory Information for PROMETHAZINE W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cenci | PROMETHAZINE W/ CODEINE | codeine phosphate; promethazine hydrochloride | SYRUP;ORAL | 088814-001 | Nov 22, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wockhardt Bio Ag | PROMETHAZINE W/ DEXTROMETHORPHAN | dextromethorphan hydrobromide; promethazine hydrochloride | SYRUP;ORAL | 088864-001 | Jan 4, 1985 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pharm Assoc | PROMETHAZINE WITH CODEINE | codeine phosphate; promethazine hydrochloride | SYRUP;ORAL | 040650-001 | Jan 31, 2006 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
